Supreme Court Lets Stand Landmark Drug Ruling

Law360, New York (October 12, 2005, 12:00 AM EDT) -- The U.S. Supreme Court has refused to hear the case against Pfizer Inc.'s blockbuster antidepressant Zoloft, letting stand an earlier decision that clarified the meaning of “actual controversy” in the pursuit of declaratory judgments.

By declining the case, the Court has also protected Zoloft, worth billions of dollars in annual sales, from early generic competition by plaintiff Teva Pharmaceuticals USA.

Israel-based Teva sued Pfizer in May 2003 in the U.S. District Court for the District of Massachusetts.

It sought declaratory judgment that its planned generic version...
To view the full article, register now.